Specifically, 4 weeks of HCA treatment attenuated the pathological features in the skin, dLNs, spleen, and blood of mice with AD without altering the basal levels of IgE in the serum of healthy mice and the basal cytokine production by T-cells in the dLNs. This evidence concerns the gene IGHE and Alzheimer disease.